Metagenics Bone Builder claims require scientific substantiation -- FTC settlement.
This article was originally published in The Tan Sheet
Executive Summary
METAGENICS BONE BUILDER EFFICACY, SUPERIORITY CLAIMS PROHIBITED without appropriate substantiation, according to an April 22 consent agreement between the Federal Trade Commission and the San Clemente, Calif.-based calcium supplement marketer. The agreement, accepted by the commission in a 5-0 vote, states that Metagenics must "rely upon competent and reliable scientific evidence to substantiate certain health, efficacy or superiority claims in the future."